Verition Fund Management LLC Bristol Myers Squibb CO Call Options Transaction History

Verition Fund Management LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $364,648 - $413,440	7,600 New	7,600 $412,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $609,472 - $721,701	-8,900 Reduced 60.54%	5,800 $417,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $1,911 - $1.13 Million	14,700 New	14,700 $1.05 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $184,440 - $221,160	3,000 Added 14.22%	24,100 $1.76 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $3.23 Million - $4.7 Million	-69,700 Reduced 76.76%	21,100 $1.18 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $1.6 Million - $2.09 Million	-32,600 Reduced 26.42%	90,800 $5.79 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $1.27 Million - $1.51 Million	-29,700 Reduced 19.4%	123,400 $6.21 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $6.83 Million - $7.55 Million	153,100 New	153,100 $6.94 Million

2,532

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.